Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Island Pharmaceuticals Ltd ( (AU:ILA) ) has provided an announcement.
Island Pharmaceuticals Ltd has announced a change in the director’s interest notice involving Phillip Lynch, who is associated with Lynch Thinking Investments Pty Ltd. Phillip Lynch has been issued 3,000,000 options, exercisable at $0.15 and expiring on 10 February 2028, with vesting conditions set for 2026 and 2027. This issuance was approved at an extraordinary general meeting held on 28 January 2025, and it reflects a strategic move by the company to align its interests with key stakeholders, potentially impacting its market dynamics and stakeholder engagement.
More about Island Pharmaceuticals Ltd
YTD Price Performance: -17.65%
Average Trading Volume: 233,865
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$25.6M
See more insights into ILA stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue